Spotting Stubborn Indirect Effects in Oligonucleotide Therapeutics

January 10th, 2023|Categories: Past Webinars|

Time: 4pm CET Date: March 16, 2023 We use chemistry to improve the properties of nucleic acid therapeutics including antisense oligonucleotides, siRNAs, and genome editing approaches. I will walk through a recent study we carried out trying to activate frataxin expression to treat ...

Towards Developing Greener Methods for Oligonucleotide Synthesis

December 26th, 2022|Categories: Past Webinars|

Time: 5pm Amsterdam - 9 AM MST Date: February 23, 2023 Research: My research focuses on the development of novel methodologies for oligonucleotide synthesis, with a particular emphasis on reducing the solvent footprint of oligonucleotide synthesis. Webinar topic: My webinar will largely focus on ...

An insider’s view into the preclinical development of an approved exon skipping drug

October 21st, 2022|Categories: Past Webinars|

Time: 11am - 12pm EST Date: November 3, 2022 Description: Dr. Arechavala works on developing new drugs for neuromuscular disorders. As there are not many for these rare diseases, neuromuscular disorders have been at the forefront of the clinical development of RNA based ...

Go to Top